Intraperitoneally injected rRNA from Pseudomonas aeruginosa combined with dimethyldioctadecylammonium bromide (DDA) increased nonspecifically the resistance of mice against an intraperitoneal challenge with extracellular (P. aeruginosa, Escherichia colt) and intracellular (Listeria monocytogenes) bacteria. This study concerns the mechanism underlying the nonspecific resistance. RNA with DDA (RNA-DDA) induced a cell influx and activated peritoneal macrophages (M4) as judged by the decreased 5'-nucleotidase and alkaline phosphodiesterase activities in M1i lysates, the enhanced O2-release, and the increased antitumor activity in comparison with unstimulated M+. RNA without DDA did not enhance the resistance and did not influence the peritoneal cell numbers or M4 properties. DDA without RNA enhanced the resistance of mice only slightly; it induced a cell influx, yielding elicited M4 as judged by the decreased 5'-nucleotidase activity and increased alkaline phosphodiesterase activity, the slightly enhanced 2-release, and the absence of increased antitumor activity. Both RNA-DDA and DDA M4 showed an enhanced capacity to ingest and kill L. monocytogenes in vitro, DDA M4 being slightly less effective than RNA-DDA M4 with respect to killing. We conclude that the enhanced killing capacity of M4 for L. monocytogenes is characteristic of both elicited DDA M4 and activated RNA-DDA M4. The relationship between nonspecific resistance, peritoneal cell numbers, and antibacterial M4 activity is discussed. In addition, it is shown that RNA and DDA retain their activity when they are injected apart, suggesting that they activate M+ by sequential action.
Intraperitoneally injected rRNA from Pseudomonas aeruginosa combined with dimethyldioctadecylammonium bromide (DDA) increased nonspecifically the resistance of mice against an intraperitoneal challenge with extracellular (P. aeruginosa, Escherichia colt) and intracellular (Listeria monocytogenes) bacteria. This study concerns the mechanism underlying the nonspecific resistance. RNA with DDA (RNA-DDA) induced a cell influx and activated peritoneal macrophages (M4) as judged by the decreased 5'-nucleotidase and alkaline phosphodiesterase activities in M1i lysates, the enhanced O2-release, and the increased antitumor activity in comparison with unstimulated M+. RNA without DDA did not enhance the resistance and did not influence the peritoneal cell numbers or M4 properties. DDA without RNA enhanced the resistance of mice only slightly; it induced a cell influx, yielding elicited M4 as judged by the decreased 5'-nucleotidase activity and increased alkaline phosphodiesterase activity, the slightly enhanced 2-release, and the absence of increased antitumor activity. Both RNA-DDA and DDA M4 showed an enhanced capacity to ingest and kill L. monocytogenes in vitro, DDA M4 being slightly less effective than RNA-DDA M4 with respect to killing. We conclude that the enhanced killing capacity of M4 for L. monocytogenes is characteristic of both elicited DDA M4 and activated RNA-DDA M4. The relationship between nonspecific resistance, peritoneal cell numbers, and antibacterial M4 activity is discussed. In addition, it is shown that RNA and DDA retain their activity when they are injected apart, suggesting that they activate M+ by sequential action.
In a previous study we demonstrated that the protection of mice by the ribonuclease-sensitive ribosomal vaccine of Pseudomonas aeruginosa was due to the synergistic action of nonspecific protection induced by the RNA and specific antibodies induced by traces of contaminating lipopolysaccharide (11) . The ribosomal vaccine and the purified RNA had to be combined with the adjuvant dimethyldioctadecylammonium bromide (DDA) to obtain protection. This study concerns the possible mechanisms whereby RNA with DDA (RNA-DDA) induced nonspecific protection. Nonspecific protection by purified RNA-DDA was achieved as soon as 1 day after immunization and lasted approximately 1 to 2 weeks. The local protection (intraperitoneal [i.p.] immunization and challenge) was greater than the systemic protection (subcutaneous immunization and i.p. challenge) (1, 11) . These characteristics of the nonspecific protection induced by RNA-DDA led us to hypothesize that RNA-DDA increased the resistance by enhancing the activity of the host's phagocytic system. RNA-DDA might increase the number of phagocytic peritoneal cells by inducing an influx. In addition, RNA-DDA might activate the macrophages (M4.), thus enhancing their phagocytic and bactericidal activity. Although nonspecific protection by ribosomal vaccines has been described (2, 3, 15, 16, 24) , no information on simultaneous MP activation is available. In this study the resistance induced by RNA-DDA is quantified for intra-and extracellular pathogens and correlated with the numbers of phagocytic peritoneal cells at the time of challenge and the characteristics of M+, including the phagocytic and killing activity of Listeria monocytogenes. (19) . The MX were challenged with 0.6 ml of a tumor cell suspension (1. analysis (t = 1 h), while two other 1-ml samples were incubated at 37°C on the rollerbank for an additional 2 h. The samples were centrifuged at t = 1 h (3,200 x g, 15 min, 4°C). The radioactivity of the supernatant was determined and expressed as counts per minute (cpm) per milliliter (A). This radioactivity was considered as background for the radioactivity in the supernatant at t = 3 h which was released from digested bacteria. The pelleted MO were lysed in 1 ml of 0.5% Triton X-100 for 30 min at 37°C on the rollerbankt The MO lysate was analyzed for the number of CFU per milliliter (B) and for radioactivity expressed as cpm per milliliter (C). At t = 3 h, samples were centrifuged at 3,200 x g for 15 min
at 4°C, and the radioactivity ih the supernatant was determined and expressed as cpm per milliliter (D). The L. monocytogenes suspension, which was added at t = 0, was diluted, with 1 volume of medium without M+, and the CFU per milliliter (F) as well as the cpm per milliliter (F) were determined. Samples (0.5 ml) to be analyzed for radioactivity were mixed with Atomlight scintillation solution (New England Nuclear Corp.) and counted in a liquid scintillation spectromneter. The CFU counts for L. monocytogenes were determined by plating on Trypticase soy agar. The following parameters were calculated: the percent uptake of bacteria by M4 at t = 1 h is (C/F) x 100; the percent viable among M4-associated bacteria at t = 1 h is (B/C) x (FIE) x 100; the percent digested bacteria after 2 h of killing of L. monocy- Peritoneal cell influx induced by RNA, DDA, or RNA-DNA. The i.p. injection of RNA-DDA and of DDA alone induced an influx of cells in the peritoneum with the highest cell numbers obtained 1 to 3 days after injection. At 6 days after the injection of RNA-DDA or DDA alone these mice contained higher numbers of peritoneal cells than PBS-treated mice ( (Table 6 ). M from DDA-pretreated mice had killed a sormewhat lower percentage of cell-associated bacteria than had RNA-DDA M4. However, M( from RNA-DDA-and DDA-pretreated mice digested similar percentages of the M4-associated bacteria during the next 2 h. M( from PBS-treated control mice were incapable of killing or digesting significant amounts of M4-associated bacteria.
When 5% BALB/c mouse serum was added during phagocytosis to provide complement for opsonization of the bacteria, the M4 from DDA-or RNA-DDA-pretreated mice took up approximately 40% of the added bacteria during 1 h of phagocytosis. The killing (percent viable among cellassociated bacteria and digestion) was similar in the prese,nce or absence of serum or only slightly increased in the presence of serum (data not shown). The effect of the time interval between injections of RNA and DDA on the PEC number and O2 release by M+. In previous experiments RNA was mixed with DDA before injection. In Table 7 experiments are presented in which RNA and DDA were injected separately at the same site b Mean of three experiments ± SE with M4 from pretreated BALB/c mice. ' One experiment ± SE with MX from pretreated C57BL mice.
(i.p.) either simultaneously or divided by various time intervals. Six days later the number of cells in the peritoneum was determined as well as the 02 release by M+~. Increased PEC numbers and increased O°-release were obtained when RNA and DDA were injected apart but at the same time, and increased 02 release was also found when RNA was injected 0.5 h after DDA. The results suggest a higher activity when RNA was injected after instead of before DDA. DISCUSSION P. aeruginosa-derived rRNA combined with DDA enhanced the nonspecific resistance of mice considerably against both extracellular bacteria and against the intracellular parasite L. monocytogenes. The previously established characteristics of the (mainly local) nonspecific resistance induced by RNA-DDA against P. aeruginosa (11) and the remarkable resistance induced against the intracellular parasite L. monocytogenes led us to hypothesize that RNA-DDA enhanced the activity of the host's phagocytic system at the site of injection. RNA-DDA treatment induced M4 that had several characteristics in common with Corynebacterium parvum or lymphokine-activ4ted M4+, i.e., decreased alkaline phosphodiesterase and 5'-nucleotidase activity, increased 02 release, and enhanced antitumor activity (5, 17 hanced capacity to kill L. monocytogenes in vitro is a characteristic of activated RNA-DDA M( as well as of elicited DDA M+. The parameters which might explain the enhanced resistance are as follows: (i) the number of peritoneal cells at the time of challenge and (ii) the phagocytic and bactericidal activity of the peritoneal macrophages. Both the number of peritoneal cells and the phagocytic and bactericidal activity of M4 are increased after treatment with RNA and DDA as well as after treatment with DDA alone. Thus, increased cell numbers and increased antibacterial activity of MX might explain why both DDA and RNA-DDA treatment results in an increased antibacterial resistance. However, the resistance expressed as LD50 induced by RNA-DDA is 10-to 100-fold higher than the resistance induced by DDA alone. RNA-DDA-treated mice contained only 1.4-to 2.5-fold more peritoneal cells than DDA-treated mice at the time of challenge, and the bactericidal activity of RNA-DDA M* is at best only slightly increased with respect to DDA M+, while their phagocytic activities are similar. Therefore we conclude that the difference between the resistance induced by RNA-DDA and by DDA alone cannot be explained by the differences in the peritoneal cell number at the time of challenge or by the phagocytic and bactericidal activity of the macrophages.
Recently, Czuprynski et al. (6) showed that listericidal MX and PMN could be elicited in normal mice by the injection of Difco Proteose Peptone. Increasing the in vivo resistance of mice by hyperimmunization with L. monocytogenes sp. did not increase the listericidal activity of proteose peptoneelicited M+. These researches explained the in vivo resistance against L. monocytogenes of immunized mice with their finding that proteose peptone elicited more peritoneal cells in Listeria-immune mice than in untreated mice. The importance of the mobilization of phagocytes to infected foci was also supported by studies with inbred mice having a different natural resistance against L. monocytogenes (23). Newborg and North (18) studied the ehhanced nonspecific resistance against L. monocytogenes in nude mice. They distinguished two phases of nonspecific antilisterial resistance, namely, a preexisting radioresistant mechanism which reduced the challenge inoculum and a subsequent radiosensitive mechanism which is induced by the challenge. This model might provide an explanation for the discrepancy between the in vivo antilisterial resistance and the in vitro listericidal activity of M+. The number and the antibacterial activity of the phagocytes at the site of the challenge are likely to determine the reduction of the challenge inoculum. However, the challenge will induce a new influx of cells. The study of Czuprynski et al. (6) suggested that the increased postchallenge cell influx in hyperimmunized mice is the most important factor in host resistance.
Our hypothesis concerning the role of DDA in the RNA-DDA mixture was that DDA formed a complex with RNA, thus protecting RNA from degradation by RNase in the host. However, it appeared that RNA and DDA also increased PEC numbers and M( activity (02-release) when they were injected apart within 0.5 h. Thus, DDA and RNA do not act exclusively as a complex, and they probably each have distinct effects on the host's phagocytic cells. Since RNA without DDA did not induce a cell influx and did not affect the activity of the resident M+, DDA might prepare or permit the action of RNA. Ruco and Meltzer (21) found that elicited MI) showed an increased responsiveness to activation by lymphokines. Johnson et al. (14) described a stepwise activation of monocytes for tumor cytolysis by sequential application of different agents. Likewise, RNA might act preferentially on influx or "primed" M+. Also, DDA, being a cationic surface-active agent (22) , might promote the attachment or penetration of RNA on or through the host's cell membrane. Preliminary experiments indicated that DDA could not be replaced by thioglycolate. However, since RNA-DDA does not act exclusively as a complex, DDA might be replaced by other eliciting agents. Such substances could have been present in other, less-purified ribosomal vaccines.
